Vascular Protective Effects of New Oral Anticoagulants in Patients with Atrial Fibrillation

This study was designed to determine the efficacy of a new oral anticoagulant (NOAC) therapy for the prevention of endothelial dysfunction and atherosclerosis progression in patients with atrial fibrillation (AF). Sixty-five AF patients with a CHA2DS2-VASc score ≥2 without previous history of cardio...

Descripción completa

Detalles Bibliográficos
Autores principales: Jang, Gyeong-Won, Lee, Jung Myung, Choi, Seung Woo, Kim, Joan, Lee, Young Shin, Kim, Hyung Oh, Chung, Hyemoon, Woo, Jong Shin, Kim, Jin Bae, Kim, Woo-Shik, Kim, Weon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509820/
https://www.ncbi.nlm.nih.gov/pubmed/34640348
http://dx.doi.org/10.3390/jcm10194332

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509820/
https://www.ncbi.nlm.nih.gov/pubmed/34640348
http://dx.doi.org/10.3390/jcm10194332

Ejemplares similares